Under the terms of the deal, GIC, one of the world’s biggest institutional investors, and healthcare-focused private equity group Linden Capital Partners will buy out a minority stake owned by rival ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies.

Most shockingly, diquat was dubbed “the worst offender” of the four weed killers. “It is 200 times more chronically toxic ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Up to 15% of older adults may be routinely taking aspirin for primary prevention, and most of them understand the excess ...

Key Takeaways 1 in 6 older adults take daily aspirin to prevent heart diseaseNearly a quarter haven’t discussed their daily ...

Germany-based life sciences giant Bayer unveiled Bayer E-Town Open Innovation Center in Beijing on Monday, adding another tier to the company's long-term commitment to Chinese healthcare.

New research warns daily aspirin use in older adults without heart disease may do more harm than good, increasing bleeding risks despite outdated beliefs about its preventive benefits.

View the latest Bayer AG (BAYN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant Xarelto in the first quarter, and he is confident that this will continue ...

Stay up to date with Herbert Bayer (Austrian, 1900 - 1985) . Discover works for sale, auction results, market data, news and exhibitions on MutualArt.